Your Clinical
Trials, But Faster

Viomedo’s end-to-end solutions help Sponsors and CROs effectively reach out to and recruit patients.

Contact
hero image

Who we are

Viomedo is the leading clinical trial platform in the German-speaking DACH region. Together with patients, patient advocacy groups and physicians, we support leading research institutions, life sciences companies and CROs with their clinical research.

Viomedo's customers include the top pharmas, biotechs and CROs

Viomedo Solutions

The number of patients that an average site enrolls is continuously declining. At the same time, competition for patients is increasing as more trials are being conducted across indications. Viomedo helps you in your recruitment efforts, enrolls patients that are beyond the reach of the selected sites and engages patients on a broad basis.

Patient Recruitment

Patient Recruitment

We reach and enroll new patients effectively by using our unique distribution network, data and technology.

Learn More
Portfolio Accessibility

Portfolio Accessibility

We make your pipeline accessible to patients and medical professionals in Germany and Austria.

Learn More
Data Services

Data Services

We deliver intelligence on trials, sites and patient populations answering questions on feasibility and startup.

Patient Recruitment

Patient Recruitment

We reach and enroll new patients effectively by using our unique distribution network, data and technology.

Learn More
Portfolio Accessibility

Portfolio Accessibility

We make your pipeline accessible to patients and medical professionals in Germany and Austria.

Learn More
Data Services

Data Services

We deliver intelligence on trials, sites and patient populations answering questions on feasibility and startup.

Viomedo Advantages

300.000

Over 300.000 patients have
used Viomedo in the second half
of 2017

15

Approval granted by over
15 ECs / IRBs in Germany and
Austria

12

Viomedo has partnered with
12 patient organizations spanning
several indications

600

Over 600 sites in Germany
and Austria have used
Viomedo

200

Viomedo provides access
to over 200 indications

40

Our team combines over
40 years of experience in
medical research

Recognized Innovation Leader

Let us tell you more

We will email you to start
the conversation.

Thank you. We’ll be in touch shortly.